Ryan C Knueppel, MD
Infectious Disease · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Knueppel’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A105175 · Current
Licensed to practise in California · since 2008 · expires 2027-09-30 · New York Medical College.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$33,057
Pharmacies billed $33,057 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 446) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
258 generic and 188 brand-name prescriptions · $33,057 in drug cost · 175 antibiotic prescriptions to 128 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Typhim Vi | 56 | $4,760 | $85 |
| Adacel Tdap | 53 | $2,703 | $51 |
| Havrix | 35 | $2,555 | $73 |
| Atovaquone-Proguanil | 44 | $1,509 | $34 |
| Rifampin | 14 | $1,430 | $102 |
See all 8 drugs
| Typhim Vi | 56 | $4,760 | $85 |
| Adacel Tdap | 53 | $2,703 | $51 |
| Havrix | 35 | $2,555 | $73 |
| Atovaquone-Proguanil | 44 | $1,509 | $34 |
| Rifampin | 14 | $1,430 | $102 |
| Ethambutol | 11 | $950 | $86 |
| Azithromycin | 107 | $818 | $8 |
| Acetazolamide | 13 | $110 | $8 |
Year by year
| 2024 | 446 | 187 | 0% (0) | 42% | $33,057 |
| 2023 | 145 | 38 | 0% (0) | None | $23,220 |
| 2022 | 168 | 46 | 0% (0) | None | $20,208 |
| 2021 | 130 | 36 | 0% (0) | None | $13,594 |
| 2020 | 100 | 35 | 0% (0) | None | $7,051 |
| 2019 | 75 | 34 | 0% (0) | None | $4,622 |
| 2018 | 51 | 29 | 0% (0) | None | $3,275 |
| 2017 | 94 | 43 | 0% (0) | 14% | $9,595 |
| 2016 | 847 | 509 | 0% (0) | 10% | $43,746 |
| 2015 | 896 | 544 | 0% (0) | 7% | $54,777 |
| 2014 | 576 | 371 | 0% (0) | None | $59,073 |
| 2013 | 315 | 228 | 0% (0) | None | $56,559 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Ethambutol | 18 | $1,539 | $85 |
| Rifampin | 17 | $1,173 | $69 |
| Doxycycline Monohydrate | 11 | $709 | $64 |
| Azithromycin | 18 | $583 | $32 |
2022: 6 drugs
| Cipro | 15 | $6,225 | $415 |
| Rifampin | 19 | $2,507 | $132 |
| Ethambutol | 21 | $1,378 | $66 |
| Doxycycline Monohydrate | 11 | $802 | $73 |
| Azithromycin | 16 | $634 | $40 |
| Cephalexin | 14 | $318 | $23 |
2021: 3 drugs
| Rifampin | 15 | $2,442 | $163 |
| Ethambutol | 22 | $1,554 | $71 |
| Azithromycin | 15 | $937 | $62 |
2020: 3 drugs
| Doxycycline Monohydrate | 14 | $1,183 | $85 |
| Azithromycin | 13 | $835 | $64 |
| Amoxicillin | 12 | $386 | $32 |
2019: 1 drug
| Amoxicillin | 14 | $423 | $30 |
2018: 1 drug
| Doxycycline Monohydrate | 15 | $1,294 | $86 |
2017: 2 drugs
| Doxycycline Monohydrate | 19 | $1,845 | $97 |
| Cephalexin | 11 | $357 | $32 |
2016: 9 drugs
| Atovaquone-Proguanil | 162 | $13,631 | $84 |
| Azithromycin | 403 | $4,219 | $10 |
| Doxycycline Monohydrate | 36 | $2,720 | $76 |
| Havrix | 37 | $1,922 | $52 |
| Acetazolamide | 50 | $1,405 | $28 |
| Twinrix | 15 | $1,140 | $76 |
| Mefloquine | 14 | $1,008 | $72 |
| Sulfamethoxazole-Trimethoprim | 18 | $721 | $40 |
| Cephalexin | 12 | $381 | $32 |
2015: 10 drugs
| Atovaquone-Proguanil | 178 | $20,115 | $113 |
| Rifampin | 19 | $6,694 | $352 |
| Azithromycin | 447 | $6,148 | $14 |
| Doxycycline Monohydrate | 35 | $3,652 | $104 |
| Ethambutol | 11 | $2,785 | $253 |
| Acetazolamide | 55 | $1,655 | $30 |
| Havrix | 28 | $1,456 | $52 |
| Mefloquine | 19 | $1,259 | $66 |
| Twinrix | 14 | $1,120 | $80 |
| Sulfamethoxazole-Trimethoprim | 14 | $686 | $49 |
2014: 9 drugs
| Atovaquone-Proguanil | 185 | $26,453 | $143 |
| Rifampin | 15 | $7,185 | $479 |
| Azithromycin | 212 | $4,211 | $20 |
| Doxycycline Monohydrate | 26 | $2,987 | $115 |
| Ethambutol | 12 | $2,823 | $235 |
| Mefloquine | 27 | $1,540 | $57 |
| Acetazolamide | 22 | $697 | $32 |
| Sulfamethoxazole-Trimethoprim | 16 | $469 | $29 |
| Ciprofloxacin | 14 | $140 | $10 |
2013: 6 drugs
| Atovaquone-Proguanil | 154 | $27,826 | $181 |
| Rifampin | 17 | $3,752 | $221 |
| Doxycycline Hyclate | 19 | $3,229 | $170 |
| Azithromycin | 15 | $2,066 | $138 |
| Mefloquine | 33 | $1,050 | $32 |
| Sulfamethoxazole-Trimethoprim | 11 | $511 | $46 |
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| SANOFI PASTEUR INC. · Sta00011 Stamaril Yellow Fever · 2019 | Their institution | $158,700 |
| SANOFI PASTEUR INC. · Sta00011 Stamaril Yellow Fever · 2020 | Their institution | $105,110 |
| SANOFI PASTEUR INC. · Sta00011 Stamaril Yellow Fever · 2021 | This clinician | $7,590 |
Professional record
- NPI
- 1184896656
- Licence
- CA 105175California A105175: Current · expires 2027-09-30
- Trained
- New York Medical College, 2002
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 710 Lawrence Expy, The Permanente Medical Group, Inc., Dept. 460, Santa Clara, CA, 95051
- NPI first listed
- 2008-03-25
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.